Proteomic analysis of outer membrane proteins and vesicles of a clinical isolate and a collection strain of Stenotrophomonas maltophilia

Journal of Proteomics

Volumn 142, Issue , 2016, Pages 122-129

  Ferrer Navarro, Mario ^a   Torrent, Gerard ^a   Mongiardini, Elías ^a   Conchillo Solé, Oscar ^a   Gibert, Isidre ^a   Daura, Xavier ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

2 DE; LC MS MS; Outer membrane proteins; Outer membrane vesicles; Stenotrophomonas maltophilia

Indexed keywords

BACTERIAL PROTEIN; OUTER MEMBRANE PROTEIN; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CELL FRACTIONATION; DELETION MUTANT; GENOTYPE; ISOELECTRIC FOCUSING; ISOELECTRIC POINT; MEMBRANE VESICLE; MOLECULAR WEIGHT; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; QUORUM SENSING; STENOTROPHOMONAS MALTOPHILIA; STRUCTURAL PROTEOMICS; UPREGULATION; ANIMAL; CHEMISTRY; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; PATHOGENICITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROCEDURES; PROTEOMICS; TANDEM MASS SPECTROMETRY; ZEBRA FISH;

ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HOST-PATHOGEN INTERACTIONS; HUMANS; PROTEOMICS; STENOTROPHOMONAS MALTOPHILIA; TANDEM MASS SPECTROMETRY; VIRULENCE FACTORS; ZEBRAFISH;

EID: 84971607490     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2016.05.001     Document Type: Article

References (72)

1. [1] Brooke, J.S., Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin. Microbiol. Rev. 25 (2012), 2–41.
2. [2] Looney, W.J., Narita, M., Muhlemann, K., Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect. Dis. 9 (2009), 312–323.
3. [3] Cervia, J.S., Ortolano, G.A., Canonica, F.P., Hospital tap water as a source of Stenotrophomonas maltophilia infection. Clin. Infect. Dis. 46 (2008), 1485–1487.
4. [4] Denton, M., Kerr, K.G., Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin. Microbiol. Rev. 11 (1998), 57–80.
5. [5] Marshall, W.F., Keating, M.R., Anhalt, J.P., Steckelberg, J.M., Xanthomonas maltophilia: an emerging nosocomial pathogen. Mayo Clin. Proc. 64 (1989), 1097–1104.
6. [6] Jang, T.N., Wang, F.D., Wang, L.S., Liu, C.Y., Liu, I.M., Xanthomonas maltophilia bacteremia: an analysis of 32 cases. J. Formos. Med. Assoc. 91 (1992), 1170–1176.
7. [7] Khardori, N., Elting, L., Wong, E., Schable, B., Bodey, G.P., Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer. Rev. Infect. Dis. 12 (1990), 997–1003.
8. [8] Vartivarian, S.E., Papadakis, K.A., Palacios, J.A., Manning, J.T. Jr., Anaissie, E.J., Mucocutaneous and soft tissue infections caused by Xanthomonas maltophilia. A new spectrum. Ann. Intern. Med. 121 (1994), 969–973.
9. [9] Denton, M., Todd, N.J., Kerr, K.G., Hawkey, P.M., Littlewood, J.M., Molecular epidemiology of Stenotrophomonas maltophilia isolated from clinical specimens from patients with cystic fibrosis and associated environmental samples. J. Clin. Microbiol. 36 (1998), 1953–1958.
10. [10] Fass, R.J., Barnishan, J., Solomon, M.C., Ayers, L.W., In vitro activities of quinolones, beta-lactams, tobramycin, and trimethoprim-sulfamethoxazole against nonfermentative gram-negative bacilli. Antimicrob. Agents Chemother. 40 (1996), 1412–1418.
11. [11] Felegie, T.P., Yu, V.L., Rumans, L.W., Yee, R.B., Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination. Antimicrob. Agents Chemother. 16 (1979), 833–837.
12. [12] Lecso-Bornet, M., Pierre, J., Sarkis-Karam, D., Lubera, S., Bergogne-Berezin, E., Susceptibility of Xanthomonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitro. Antimicrob. Agents Chemother. 36 (1992), 669–671.
13. [13] Toleman, M.A., Bennett, P.M., Bennett, D.M., Jones, R.N., Walsh, T.R., Global emergence of trimethoprim/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes. Emerg. Infect. Dis. 13 (2007), 559–565.
14. [14] Zhang, L., Li, X.Z., Poole, K., Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system. Antimicrob. Agents Chemother. 44 (2000), 287–293.
15. [15] Crossman, L.C., Gould, V.C., Dow, J.M., Vernikos, G.S., Okazaki, A., Sebaihia, M., et al. The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol., 9, 2008, R74.
16. [16] Liaw, S.J., Lee, Y.L., Hsueh, P.R., Multidrug resistance in clinical isolates of Stenotrophomonas maltophilia: roles of integrons, efflux pumps, phosphoglucomutase (SpgM), and melanin and biofilm formation. Int. J. Antimicrob. Agents 35 (2010), 126–130.
17. [17] Schell, M.A., Zhao, P., Wells, L., Outer membrane proteome of Burkholderia pseudomallei and Burkholderia mallei from diverse growth conditions. J. Proteome Res. 10 (2011), 2417–2424.
18. [18] Kuehn, M.J., Kesty, N.C., Bacterial outer membrane vesicles and the host–pathogen interaction. Genes Dev. 19 (2005), 2645–2655.
19. [19] Bauman, S.J., Kuehn, M.J., Purification of outer membrane vesicles from Pseudomonas aeruginosa and their activation of an IL-8 response. Microbes Infect. 8 (2006), 2400–2408.
20. [20] Fiocca, R., Necchi, V., Sommi, P., Ricci, V., Telford, J., Cover, T.L., et al. Release of Helicobacter pylori vacuolating cytotoxin by both a specific secretion pathway and budding of outer membrane vesicles. Uptake of released toxin and vesicles by gastric epithelium. J. Pathol. 188 (1999), 220–226.
21. [21] Hoekstra, D., van der Laan, J.W., de Leij, L., Witholt, B., Release of outer membrane fragments from normally growing Escherichia coli. Biochim. Biophys. Acta Biomembr. 455 (1976), 889–899.
22. [22] Kondo, K., Takade, A., Amako, K., Release of the outer membrane vesicles from Vibrio cholerae and Vibrio parahaemolyticus. Microbiol. Immunol. 37 (1993), 149–152.
23. [23] Nevot, M., Deroncele, V., Messner, P., Guinea, J., Mercade, E., Characterization of outer membrane vesicles released by the psychrotolerant bacterium Pseudoalteromonas antarctica NF3. Environ. Microbiol. 8 (2006), 1523–1533.
24. [24] Wai, S.N., Lindmark, B., Söderblom, T., Takade, A., Westermark, M., Oscarsson, J., et al. Vesicle-mediated export and assembly of pore-forming oligomers of the enterobacterial ClyA cytotoxin. Cell 115 (2003), 25–35.
25. [25] Kadurugamuwa, J.L., Beveridge, T.J., Bacteriolytic effect of membrane vesicles from Pseudomonas aeruginosa on other bacteria including pathogens: conceptually new antibiotics. J. Bacteriol. 178 (1996), 2767–2774.
26. [26] Li, Z., Clarke, A.J., Beveridge, T.J., Gram-negative bacteria produce membrane vesicles which are capable of killing other bacteria. J. Bacteriol. 180 (1998), 5478–5483.
27. [27] Ciofu, O., Beveridge, T.J., Kadurugamuwa, J., Walther-Rasmussen, J., Hoiby, N., Chromosomal beta-lactamase is packaged into membrane vesicles and secreted from Pseudomonas aeruginosa. J. Antimicrob. Chemother. 45 (2000), 9–13.
28. [28] Mashburn, L.M., Whiteley, M., Membrane vesicles traffic signals and facilitate group activities in a prokaryote. Nature 437 (2005), 422–425.
29. [29] Ferrari, G., Garaguso, I., Adu-Bobie, J., Doro, F., Taddei, A.R., Biolchi, A., et al. Outer membrane vesicles from group B Neisseria meningitidis delta gna33 mutant: proteomic and immunological comparison with detergent-derived outer membrane vesicles. Proteomics 6 (2006), 1856–1866.
30. [30] Nally, J.E., Whitelegge, J.P., Aguilera, R., Pereira, M.M., Blanco, D.R., Lovett, M.A., Purification and proteomic analysis of outer membrane vesicles from a clinical isolate of Leptospira interrogans serovar Copenhageni. Proteomics 5 (2005), 144–152.
31. [31] Uli, L., Castellanos-Serra, L., Betancourt, L., Dominguez, F., Barbera, R., Sotolongo, F., et al. Outer membrane vesicles of the VA-MENGOC-BC vaccine against serogroup B of Neisseria meningitidis: analysis of protein components by two-dimensional gel electrophoresis and mass spectrometry. Proteomics 6 (2006), 3389–3399.
32. [32] Vipond, C., Suker, J., Jones, C., Tang, C., Feavers, I.M., Wheeler, J.X., Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98/254. Proteomics 6 (2006), 3400–3413.
33. [33] Ferrer-Navarro, M., Planell, R., Yero, D., Mongiardini, E., Torrent, G., Huedo, P., et al. Abundance of the quorum-sensing factor Ax21 in four strains of correlates with mortality rate in a new zebrafish model of infection. PLoS ONE, 8, 2013, e67207.
34. [34] Hugh, R., Ryschenkow, E., Pseudomonas maltophilia, an alcaligenes-like species. J. Gen. Microbiol. 26 (1961), 123–132.
35. [35] Hobb, R.I., Fields, J.A., Burns, C.M., Thompson, S.A., Evaluation of procedures for outer membrane isolation from Campylobacter jejuni. Microbiology 155 (2009), 979–988.
36. [36] Horstman, A.L., Kuehn, M.J., Enterotoxigenic Escherichia coli secretes active heat-labile enterotoxin via outer membrane vesicles. J. Biol. Chem. 275 (2000), 12489–12496.
37. [37] Lee, E.Y., Bang, J.Y., Park, G.W., Choi, D.S., Kang, J.S., Kim, H.J., et al. Global proteomic profiling of native outer membrane vesicles derived from Escherichia coli. Proteomics 7 (2007), 3143–3153.
38. [38] Görg, A., Weiss, W., Dunn, M.J., Current two-dimensional electrophoresis technology for proteomics. Proteomics 4 (2004), 3665–3685.
39. [39] Párraga-Niño, N., Colomé-Calls, N., Canals, F., Querol, E., Ferrer-Navarro, M., A comprehensive proteome of Mycoplasma genitalium. J. Proteome Res. 11 (2012), 3305–3316.
40. [40] Shevchenko, A., Wilm, M., Vorm, O., Mann, M., Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Anal. Chem. 68 (1996), 850–858.
41. [41] Davenport, K.W., Daligault, H.E., Minogue, T.D., Broomall, S.M., Bruce, D.C., Chain, P.S., et al. Complete genome sequence of Stenotrophomonas maltophilia type strain 810-2 (ATCC 13637). Genome Announcements, 2, 2014.
42. [42] Huedo, P., Conchillo-Solé, Ó., Yero, D., Martínez-Servat, S., Daura, X., Gibert, I., Draft genome sequence of Stenotrophomonas maltophilia strain M30, isolated from a chronic pressure ulcer in an elderly patient. Genome Announcements, 2, 2014.
43. [43] Elias, J.E., Haas, W., Faherty, B.K., Gygi, S.P., Comparative evaluation of mass spectrometry platforms used in large-scale proteomics investigations. Nat. Methods 2 (2005), 667–675.
44. [44] Cao, Y., Johnson, H.M., Bazemore-Walker, C.R., Improved enrichment and proteomic identification of outer membrane proteins from a Gram-negative bacterium: focus on Caulobacter crescentus. Proteomics 12 (2012), 251–262.
45. [45] Chevallet, M., Santoni, V., Poinas, A., Rouquie, D., Fuchs, A., Kieffer, S., et al. New zwitterionic detergents improve the analysis of membrane proteins by two-dimensional electrophoresis. Electrophoresis 19 (1998), 1901–1909.
46. [46] Molloy, M.P., Herbert, B.R., Slade, M.B., Rabilloud, T., Nouwens, A.S., Williams, K.L., et al. Proteomic analysis of the Escherichia coli outer membrane. European journal of biochemistry/FEBS 267 (2000), 2871–2881.
47. [47] Yu, N.Y., Wagner, J.R., Laird, M.R., Melli, G., Rey, S., Lo, R., et al. PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinformatics 26 (2010), 1608–1615.
48. [48] Devos, S., Van Oudenhove, L., Stremersch, S., Van Putte, W., Derycke, R., Van Driessche, G., et al. The effect of imipenem and diffusible signaling factors on the secretion of outer membrane vesicles and associated Ax21 proteins in Stenotrophomonas maltophilia. Front. Microbiol., 6, 2015.
49. [49] McCarthy, Y., Dow, J.M., Ryan, R.P., The Ax21 protein is a cell-cell signal that regulates virulence in the nosocomial pathogen Stenotrophomonas maltophilia. J. Bacteriol. 193 (2011), 6375–6378.
50. [50] Collao, B., Morales, E.H., Gil, F., Calderon, I.L., Saavedra, C.P., ompW is cooperatively upregulated by MarA and SoxS in response to menadione. Microbiology 159 (2013), 715–725.
51. [51] Nandi, B., Nandy, R.K., Sarkar, A., Ghose, A.C., Structural features, properties and regulation of the outer-membrane protein W (OmpW) of Vibrio cholerae. Microbiology 151 (2005), 2975–2986.
52. [52] Pilsl, H., Smajs, D., Braun, V., Characterization of colicin S4 and its receptor, OmpW, a minor protein of the Escherichia coli outer membrane. J. Bacteriol. 181 (1999), 3578–3581.
53. [53] Cao, Z., Klebba, P.E., Mechanisms of colicin binding and transport through outer membrane porins. Biochimie 84 (2002), 399–412.
54. [54] Zhang, L., Li, X.Z., Poole, K., SmeDEF multidrug efflux pump contributes to intrinsic multidrug resistance in Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 45 (2001), 3497–3503.
55. [55] Renelli, M., Matias, V., Lo, R.Y., Beveridge, T.J., DNA-containing membrane vesicles of Pseudomonas aeruginosa PAO1 and their genetic transformation potential. Microbiology 150 (2004), 2161–2169.
56. [56] Van Oudenhove, L., De Vriendt, K., Van Beeumen, J., Mercuri, P., Devreese, B., Differential proteomic analysis of the response of Stenotrophomonas maltophilia to imipenem. Appl. Microbiol. Biotechnol. 95 (2012), 717–733.
57. [57] Galdiero, M., Folgore, A., Molitierno, M., Greco, R., Porins and lipopolysaccharide (LPS) from Salmonella typhimurium induce leucocyte transmigration through human endothelial cells in vitro. Clin. Exp. Immunol. 116 (1999), 453–461.
58. [58] Kobayashi, H., Uematsu, K., Hirayama, H., Horikoshi, K., Novel toluene elimination system in a toluene-tolerant microorganism. J. Bacteriol. 182 (2000), 6451–6455.
59. [59] Loeb, M.R., Kilner, J., Release of a special fraction of the outer membrane from both growing and phage T4-infected Escherichia coli B. Biochim. Biophys. Acta 514 (1978), 117–127.
60. [60] Mashburn-Warren, L.M., Whiteley, M., Special delivery: vesicle trafficking in prokaryotes. Mol. Microbiol. 61 (2006), 839–846.
61. [61] Shoberg, R.J., Thomas, D.D., Specific adherence of Borrelia burgdorferi extracellular vesicles to human endothelial cells in culture. Infect. Immun. 61 (1993), 3892–3900.
62. [62] Payne, D.J., Cramp, R., Bateson, J.H., Neale, J., Knowles, D., Rapid identification of metallo- and serine beta-lactamases. Antimicrob. Agents Chemother. 38 (1994), 991–996.
63. [63] Sanschagrin, F., Dufresne, J., Levesque, R.C., Molecular heterogeneity of the L-1 metallo-beta-lactamase family from Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 42 (1998), 1245–1248.
64. [64] Walsh, T.R., MacGowan, A.P., Bennett, P.M., Sequence analysis and enzyme kinetics of the L2 serine beta-lactamase from Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 41 (1997), 1460–1464.
65. [65] King, B.A., Shannon, K.P., Phillips, I., Aminoglycoside 6′-N acetyltransferase production by an isolate of Pseudomonas maltophilia. J. Antimicrob. Chemother. 4 (1978), 467–468.
66. [66] Lambert, T., Ploy, M.C., Denis, F., Courvalin, P., Characterization of the chromosomal aac(6′)-Iz gene of Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 43 (1999), 2366–2371.
67. [67] Vanhoof, R., Sonck, P., Hannecart-Pokorni, E., The role of lipopolysaccharide anionic binding sites in aminoglycoside uptake in Stenotrophomonas (Xanthomonas) maltophilia. J. Antimicrob. Chemother. 35 (1995), 167–171.
68. [68] Ingmer, H., Brondsted, L., Proteases in bacterial pathogenesis. Res. Microbiol. 160 (2009), 704–710.
69. [69] Kadurugamuwa, J.L., Beveridge, T.J., Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion. J. Bacteriol. 177 (1995), 3998–4008.
70. [70] Dorward, D.W., Garon, C.F., Judd, R.C., Export and intercellular transfer of DNA via membrane blebs of Neisseria gonorrhoeae. J. Bacteriol. 171 (1989), 2499–2505.
71. [71] Kolling, G.L., Matthews, K.R., Export of virulence genes and Shiga toxin by membrane vesicles of Escherichia coli O157:H7. Appl. Environ. Microbiol. 65 (1999), 1843–1848.
72. [72] Yaron, S., Kolling, G.L., Simon, L., Matthews, K.R., Vesicle-mediated transfer of virulence genes from Escherichia coli O157:H7 to other enteric bacteria. Appl. Environ. Microbiol. 66 (2000), 4414–4420.